Effect of Patient Immune Status on the Efficacy of Radiation Therapy and Recurrence-Free Survival Among 805 Patients With Merkel Cell Carcinoma.

MLA

Tseng, Yolanda D., et al. “Effect of Patient Immune Status on the Efficacy of Radiation Therapy and Recurrence-Free Survival Among 805 Patients With Merkel Cell Carcinoma.” International Journal of Radiation Oncology, Biology, Physics, vol. 102, no. 2, Oct. 2018, pp. 330–39. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2018.05.075.

APA

Tseng, Y. D., Nguyen, M. H., Baker, K., Cook, M., Redman, M., Lachance, K., Bhatia, S., Liao, J. J., Apisarnthanarax, S., Nghiem, P. T., & Parvathaneni, U. (2018). Effect of Patient Immune Status on the Efficacy of Radiation Therapy and Recurrence-Free Survival Among 805 Patients With Merkel Cell Carcinoma. International Journal of Radiation Oncology, Biology, Physics, 102(2), 330–339. https://doi.org/10.1016/j.ijrobp.2018.05.075

Chicago

Tseng, Yolanda D, Macklin H Nguyen, Kelsey Baker, Maclean Cook, Mary Redman, Kristina Lachance, Shailender Bhatia, et al. 2018. “Effect of Patient Immune Status on the Efficacy of Radiation Therapy and Recurrence-Free Survival Among 805 Patients With Merkel Cell Carcinoma.” International Journal of Radiation Oncology, Biology, Physics 102 (2): 330–39. doi:10.1016/j.ijrobp.2018.05.075.